22:56 , Apr 20, 2018 |  BioCentury  |  Emerging Company Profile

Clear for Landos

Landos Biopharma Inc. is developing a first-in-class LANCL2 agonist designed to provide improved convenience, efficacy and safety over standard-of-care therapies for inflammatory bowel disease (IBD), including moderate to severe Crohn’s disease (CD) and ulcerative colitis...
19:51 , Sep 22, 2017 |  BC Week In Review  |  Financial News

Landos spins out of Xontogeny accelerator

On Sept. 21, Landos Biopharma Inc. (Blacksburg, Va.) spun out of life sciences accelerator Xontogeny LLC (Boston, Mass) with the first $5 million tranche of a $10 million series A round from Perceptive Advisors. CEO...
12:09 , Sep 21, 2017 |  BC Extra  |  Financial News

Landos spins out of Xontogeny accelerator

Landos Biopharma Inc. (Blacksburg, Va.) spun out of life sciences accelerator Xontogeny LLC (Boston, Mass) and raised the first $5 million tranche of a $10 million series A round from Perceptive Advisors. CEO Josep Bassaganya-Riera...
07:00 , May 24, 2004 |  BC Week In Review  |  Clinical News

Bt-11 sweet corn regulatory update

The EC authorized the marketing of Bt-11 sweet corn from SYNN as canned or fresh food. The decision, which is valid for 10 years, does not include the approval of Bt-11 sweet corn for cultivation...
07:00 , May 24, 2004 |  BioCentury  |  Politics, Policy & Law

EU gags on patents, goes for the corn

Despite the opposition of several member states, the EU Commission last week ended an almost six-year moratorium on GMOs by authorizing the import and marketing of Syngenta International AG's Bt-11 corn for human consumption. The...
07:00 , May 19, 2004 |  BC Extra  |  Company News

EU approves import of GM corn for food

The European Commission authorized the marketing of Bt-11 sweet corn from Syngenta (SWX:SYNN; SYT) as canned or fresh food. The decision, which is valid for 10 years, does not include the approval of Bt-11 sweet...
07:00 , Apr 27, 2004 |  BC Extra  |  Politics & Policy

EU agriculture ministers split on GM corn

The agriculture ministers of the EU members states did not approve for import the BT-11 genetically modified (GM) corn borer resistant sweet corn from Syngenta (SWX:SYNN; SYT), after voting 6-6 with 3 abstentions. An approval...
07:00 , Oct 19, 1998 |  BC Week In Review  |  Clinical News

Novartis Seeds Inc. regulatory update

Switzerland granted marketing approval for Novartis' Bt-11 maize, which is resistant to the European corn borer, for use in food and animal feed. Novartis Seeds Inc., Golden Valley, Minn.   Business: Agbio/Veterinary/Environmental  ...
07:00 , Jun 15, 1998 |  BC Week In Review  |  Clinical News

Novartis International AG regulatory update

The European Union granted marketing approval to Novartis' Bt-11 genetically improved corn for use in food and animal feed. The product protects against the European corn borer and pink stem borer. Novartis International AG, Basel,...
08:00 , Mar 23, 1998 |  BioCentury  |  Politics, Policy & Law

GMOs edge forward

AgrEvo, Monsanto and Novartis have moved closer to being able to commercialize a number of genetically modified seeds in Europe. Members of the regulatory committee overseeing Directive 90/220/EEC, the so-called deliberate release into the environment...